Amylyx Pharmaceuticals Inc
AMLX7.930USD
+0.215+2.79%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
706.41MMarket Cap
LossP/E TTM
Amylyx Pharmaceuticals Inc
7.930
+0.215+2.79%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q2
FY2021Q1
FY2020Q4
Total revenue
-100.00%0.00
-100.61%-665.00K
-99.59%416.00K
-101.04%-1.02M
24.10%88.64M
395.54%108.45M
29666.09%102.69M
--98.22M
--71.43M
--21.89M
--345.00K
----
----
-100.00%0.00
----
----
--350.00K
Revenue
-100.00%0.00
-100.61%-665.00K
-99.59%416.00K
-101.04%-1.02M
24.10%88.64M
395.54%108.45M
29666.09%102.69M
--98.22M
--71.43M
--21.89M
--345.00K
----
----
-100.00%0.00
----
----
--350.00K
Cost of revenue
-100.00%0.00
-100.00%0.00
-84.50%809.00K
32.94%7.42M
352.51%23.91M
231.80%9.36M
2933.72%5.22M
--5.58M
--5.28M
--2.82M
--172.00K
----
----
----
----
----
----
Operating expenses
-68.04%37.80M
-61.83%40.65M
-52.52%39.87M
-32.82%52.41M
60.96%118.27M
60.23%106.52M
52.61%83.97M
43.80%78.02M
53.68%73.48M
134.78%66.48M
--55.03M
191.89%54.25M
271.57%47.81M
216.65%28.32M
--18.59M
--12.87M
--8.94M
R&D expenses
-39.58%22.12M
-49.03%22.89M
-29.30%21.24M
-19.62%23.35M
51.32%36.61M
96.88%44.91M
20.56%30.04M
19.72%29.04M
12.71%24.19M
70.32%22.81M
--24.91M
121.97%24.26M
212.70%21.46M
167.19%13.39M
--10.93M
--6.86M
--5.01M
Depreciation, depletion, and amortization
-50.48%156.00K
-46.84%160.00K
-26.82%221.00K
-25.98%208.00K
54.41%315.00K
65.38%301.00K
83.03%302.00K
167.62%281.00K
482.86%204.00K
727.27%182.00K
--165.00K
950.00%105.00K
250.00%35.00K
2100.00%22.00K
--10.00K
--10.00K
--1.00K
Other operating expenses
----
--665.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-27.58%-37.80M
-2202.07%-40.65M
-310.78%-39.46M
-364.52%-53.44M
-1343.25%-29.63M
104.34%1.93M
134.23%18.72M
137.23%20.20M
95.71%-2.05M
-57.49%-44.59M
---54.68M
-191.89%-54.25M
-271.57%-47.81M
-229.55%-28.32M
---18.59M
---12.87M
---8.59M
Net non-operating interest income (expenses)
Non-operating interest income
-48.43%2.23M
-47.01%2.32M
-25.87%3.10M
4.68%4.07M
16.35%4.33M
38.45%4.37M
595.34%4.18M
866.92%3.89M
2738.17%3.72M
10423.33%3.16M
--601.00K
40100.00%402.00K
6450.00%131.00K
--30.00K
--1.00K
--2.00K
--0.00
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
--1.00K
Special income (expenses)
----
--0.00
---36.20M
---22.85M
---92.50M
--0.00
----
----
----
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
---3.31M
---1.92M
--0.00
Other non-operating income (expenses)
55.15%-335.00K
-8.19%157.00K
71.11%-141.00K
-496.30%-483.00K
-185.11%-747.00K
124.82%171.00K
-345.23%-488.00K
-92.86%-81.00K
-1278.95%-262.00K
-1067.80%-689.00K
--199.00K
-61.54%-42.00K
-107.28%-19.00K
-6000.00%-59.00K
---26.00K
--261.00K
--1.00K
Income before tax
69.71%-35.91M
-689.58%-38.18M
-424.41%-72.70M
-402.83%-72.70M
-8549.82%-118.55M
115.37%6.48M
141.59%22.41M
144.55%24.01M
102.94%1.40M
-48.62%-42.13M
---53.88M
-145.84%-53.89M
-228.46%-47.70M
-229.89%-28.34M
---21.92M
---14.52M
---8.59M
Income tax
-100.00%0.00
-136.39%-635.00K
----
-100.00%0.00
242.35%242.00K
201.38%1.75M
1314.40%1.52M
1010.92%1.93M
-216.44%-170.00K
--579.00K
---125.00K
--174.00K
--146.00K
----
--0.00
--0.00
----
Income after tax
69.77%-35.91M
-893.62%-37.55M
-447.98%-72.70M
-429.35%-72.70M
-7652.00%-118.79M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-50.66%-42.70M
---53.76M
-146.63%-54.07M
-229.46%-47.85M
-229.89%-28.34M
---21.92M
---14.52M
---8.59M
Net income from continuous operations
69.77%-35.91M
-893.62%-37.55M
-447.98%-72.70M
-429.35%-72.70M
-7652.00%-118.79M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-50.66%-42.70M
---53.76M
-146.63%-54.07M
-229.46%-47.85M
-229.89%-28.34M
---21.92M
---14.52M
---8.59M
Net income attributable to controlling interests
69.77%-35.91M
-893.62%-37.55M
-447.98%-72.70M
-429.35%-72.70M
-7652.00%-118.79M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-50.66%-42.70M
---53.76M
-146.63%-54.07M
-229.46%-47.85M
-229.89%-28.34M
---21.92M
---14.52M
---8.59M
Net income attributable to common shareholders
69.77%-35.91M
-893.62%-37.55M
-447.98%-72.70M
-429.35%-72.70M
-7652.00%-118.79M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-50.66%-42.70M
---53.76M
-146.63%-54.07M
-229.46%-47.85M
-229.89%-28.34M
---21.92M
---14.52M
---8.59M
Basic earnings per share
76.07%-0.42
-881.69%-0.55
-444.52%-1.07
-425.51%-1.07
-7524.55%-1.75
110.74%0.07
133.75%0.31
135.39%0.33
102.54%0.02
-29.90%-0.65
---0.92
-138.98%-0.93
-260.50%-0.93
-229.90%-0.50
---0.39
---0.26
---0.15
Diluted earnings per share
76.07%-0.42
-904.44%-0.55
-456.45%-1.07
-439.55%-1.07
-7986.08%-1.75
110.43%0.07
132.62%0.30
133.93%0.31
102.39%0.02
-29.90%-0.65
---0.92
-138.98%-0.93
-260.50%-0.93
-229.90%-0.50
---0.39
---0.26
---0.15
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
